How Much Does HealthRX Cost? GLP-1 Prices and Fees (2026)

HealthRX lists compounded semaglutide from $97/mo (12-month Subscribe & Save plan rate; $1,163 charged per 12 months), verified October 6, 2026, medication included. Plus tirzepatide, plan terms and fees, each dated.

By RangeYourselfEach figure shows its own verification date

HealthRX lists compounded semaglutide (injectable) from $97/mo (12-month Subscribe & Save plan rate; $1,163 charged per 12 months), verified October 6, 2026, medication included. Compounded tirzepatide: $177/mo (12-month plan; $2,123 charged per 12 months), verified October 6, 2026. Membership: no separate membership fee in our records, verified October 6, 2026. Plan terms and fees are below. Where this page does not state a fact, we do not estimate it.

HealthRX price at a glance

Item	What our records show
Semaglutide	$97/mo (12-month Subscribe & Save plan rate; $1,163 charged per 12 months)Price verified October 6, 2026. Plan term: 12-month. Medication: compounded semaglutide (injectable).
Tirzepatide	$177/mo (12-month plan; $2,123 charged per 12 months)Price verified October 6, 2026. Plan term: 12-month. Medication: compounded tirzepatide.
Membership fee	no separate membership fee in our records, verified October 6, 2026
Medication offered	compounded

Month-to-month vs commitment pricing

Plan term	What the price covers	Per month	Plan charge	Verified
Month-to-month (1-month plan)	Compounded semaglutide (injectable)	$165/mo	$165 per month (first month $149 under the company's first-month offer)	October 6, 2026
3-month plan	Compounded semaglutide (injectable)	$125/mo	$374 per 3 months	October 6, 2026
6-month plan	Compounded semaglutide (injectable)	$115/mo	$689 per 6 months	October 6, 2026
12-month plan	Compounded semaglutide (injectable)	$97/mo	$1,163 per 12 months	October 6, 2026
Month-to-month (1-month plan)	Compounded tirzepatide (injectable)	$214/mo	$214 per month (first month $193 under the company's first-month offer)	October 6, 2026
3-month plan	Compounded tirzepatide	$201/mo	$602 per 3 months	October 6, 2026
6-month plan	Compounded tirzepatide	$195/mo	$1,169 per 6 months	October 6, 2026
12-month plan	Compounded tirzepatide (injectable)	$177/mo	$2,123 per 12 months	October 6, 2026

Each row is a separate plan record with its own verification date. This table lists only the plan terms we have verified in a form we can date; HealthRX may offer other terms.

Month-to-month semaglutide: $165/mo, with a first month of $149 under the company's first-month offer, from the plan record above (verified October 6, 2026).

Membership, visit and shipping fees

Membership fee: no separate membership fee in our records, verified October 6, 2026.
Shipping: HealthRX states: “Free overnight shipping · All 50 states” (read September 8, 2026).
Labs: not stated on this page. Confirm at intake.
Other charges: HealthRX states: “There are no separate visit fees or membership fees.” (read September 8, 2026).

Dose pricing and the first month

This page does not state a dose-by-dose price schedule for HealthRX, which may publish one. First-month prices the company states are in the plan table above. See HealthRX’s pricing page (healthrx.com) for current dose pricing, any introductory offer and the first charge. Offers change and can end.

Where these prices come from

Headline prices are read from healthrx.com, HealthRX’s own site. Each figure shows its own verification date and the dates differ between figures. Providers can change prices without notice, so treat any figure as a dated snapshot.

Lower-priced verified options

Price comparison: semaglutide programs priced below HealthRX

HealthRX’s own verified semaglutide figure is $97/mo (12-month Subscribe & Save plan rate; $1,163 charged per 12 months), verified October 6, 2026. The programs below list a lower verified price for semaglutide with the medication included, ranked lowest first. Plan terms and price types differ between programs, so read the label beside each figure. This is a price comparison, not a statement about quality or fit.

1.Embody
$69/mo (limited-time promo, no standing price confirmed), verified September 17, 2026
Medication: semaglutide, compounded. Plan term: this page does not state a plan term for this price.
See pricing →

Each figure is the price shown, labelled with its plan term where we have verified one, and its own verification date. Programs are ordered by price. Programs at the same listed price are labeled; only where tied programs are also identical on every detail we track may programs that pay RangeYourself a commission be listed first.

Price comparison: tirzepatide programs priced below HealthRX

HealthRX’s own verified tirzepatide figure is $177/mo (12-month plan; $2,123 charged per 12 months), verified October 6, 2026. The programs below list a lower verified price for tirzepatide with the medication included, ranked lowest first. Plan terms and price types differ between programs, so read the label beside each figure. This is a price comparison, not a statement about quality or fit.

1.Embody
$119/mo (flat monthly pricing, limited-time promo offer, no standing price confirmed), verified September 17, 2026
Medication: tirzepatide, compounded. Plan term: monthly.
See pricing →
2.Trimi
$125/mo (annual plan; prepaid annually), verified August 21, 2026, more than six weeks ago
Medication: tirzepatide, compounded. Plan term: annual.
See pricing →
3.Sprout Health
$149/mo (12-month plan; $1,788 charged per 12 months), verified October 6, 2026 | Same listed price ($149/mo), different plan terms or formats
Medication: tirzepatide, compounded and brand-name options offered. Plan term: 12-month.
See pricing →
4.Strut Health
$149/mo (injectable), verified September 28, 2026 | Same listed price ($149/mo), different plan terms or formats
Medication: tirzepatide, compounded. Plan term: this page does not state a plan term for this price.
See pricing →
5.TMates
$167/mo (12-month plan), verified July 14, 2026, more than three months ago
Medication: tirzepatide, compounded. Plan term: 12-month.
See pricing →

See HealthRX pricing → Read the full HealthRX review →

Frequently asked questions

How much does HealthRX cost per month?

HealthRX lists compounded semaglutide (injectable) from $97/mo (12-month Subscribe & Save plan rate; $1,163 charged per 12 months), verified October 6, 2026, with the medication included. Compounded tirzepatide is $177/mo (12-month plan; $2,123 charged per 12 months), verified October 6, 2026. Membership: no separate membership fee in our records, verified October 6, 2026. Prices change, so confirm the current figure with HealthRX before you enrol.

How much is HealthRX semaglutide?

HealthRX lists compounded semaglutide (injectable) at $97/mo (12-month Subscribe & Save plan rate; $1,163 charged per 12 months), verified October 6, 2026. Prices change, so confirm the current figure with HealthRX.

How much is HealthRX tirzepatide?

HealthRX lists compounded tirzepatide at $177/mo (12-month plan; $2,123 charged per 12 months), verified October 6, 2026. Prices change, so confirm the current figure with HealthRX.

Does HealthRX charge a membership fee?

Our records show no separate membership fee for HealthRX, verified October 6, 2026.

Is there a lower-priced GLP-1 program than HealthRX?

Among the programs in our verified Price Index, 1 lists a lower all-in monthly semaglutide price than HealthRX's $97/mo (12-month Subscribe & Save plan rate; $1,163 charged per 12 months). The lowest: Embody at $69/mo (limited-time promo, no standing price confirmed), verified September 17, 2026. Plan terms and price types differ, so check the label beside each figure. This is a price comparison, not a statement about quality or fit.

When was HealthRX's price last verified?

Each price on this page carries its own verification date, shown beside it, and the dates differ between figures. Providers can change prices without notice, so treat any figure as a dated snapshot and confirm it at checkout.

Cost pages for other programs

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Each price on this page carries the date it was verified, and prices may have changed since.